CpG 1018 通过增强 CD8+ T 细胞反应来增强 mRNA 疫苗诱导的抗肿瘤免疫 CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses. PubMed 2026/05/09 发表Mol Ther OncolQ1 · IF 8.5(JCR 2025) 技术:NK 细胞技术:mRNA胰腺癌乳腺癌黑色素瘤地区:美国
用 mRNA 治疗重编程三阴性乳腺癌的免疫微环境 Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics. PubMed 2026/02/21 发表Cancer LettQ1 · IF 11.8(JCR 2025) 靶点:HER2靶点:ROR1靶点:NY-ESO-1技术:CAR-T技术:TCR-T技术:mRNA
革新肿瘤治疗:免疫治疗的最新进展 Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy. PubMed 2024/09/23 发表BiomedicinesQ2 · IF 4.5(JCR 2025) 技术:CAR-T技术:基因编辑技术:mRNA乳腺癌肺癌淋巴瘤